<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Genet</journal-id><journal-title>BMC Genetics</journal-title><issn pub-type="epub">1471-2156</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-2156-7-13</article-id><article-id pub-id-type="pmid">16515703</article-id><article-id pub-id-type="doi">10.1186/1471-2156-7-13</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Characterization of the canine <italic>CLCN3 </italic>gene and evaluation as candidate for late-onset NCL</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Wohlke</surname><given-names>Anne</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>anne.woehlke@tiho-hannover.de</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Distl</surname><given-names>Ottmar</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>ottmar.distl@tiho-hannover.de</email></contrib><contrib id="A3" corresp="yes" contrib-type="author"><name><surname>Drogemuller</surname><given-names>Cord</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>cord.droegemueller@itz.unibe.ch</email></contrib></contrib-group><aff id="I1"><label>1</label>Institute for Animal Breeding and Genetics, University of Veterinary Medicine Hannover, B&#x000fc;nteweg 17p, 30559 Hannover, Germany</aff><aff id="I2"><label>2</label>Institute of Genetics, Vetsuisse, University of Berne, Bremgartenstrasse 109a, 3001 Berne, Switzerland</aff><pub-date pub-type="collection"><year>2006</year></pub-date><pub-date pub-type="epub"><day>3</day><month>3</month><year>2006</year></pub-date><volume>7</volume><fpage>13</fpage><lpage>13</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2156/7/13"/><history><date date-type="received"><day>10</day><month>12</month><year>2005</year></date><date date-type="accepted"><day>3</day><month>3</month><year>2006</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2006 Wohlke et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2006</copyright-year><copyright-holder>Wohlke et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Wohlke Anne anne.woehlke@tiho-hannover.de </dc:author><dc:title> Characterization of the canine CLCN3 gene and evaluation as candidate for late-onset NCL </dc:title><dc:date>2006</dc:date><dcterms:bibliographicCitation>BMC Genetics 7(1): 13-. (2006)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2156(2006)7:1&#x0003c;13&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2156</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>The neuronal ceroid lipofuscinoses (NCL) are a heterogenous group of inherited progressive neurodegenerative diseases in different mammalian species. Tibetan Terrier and Polish Owczarek Nizinny (PON) dogs show rare late-onset NCL variants with autosomal recessive inheritance, which can not be explained by mutations of known human NCL genes. These dog breeds represent animal models for human late-onset NCL. In mice the chloride channel 3 gene (<italic>Clcn3</italic>) encoding an intracellular chloride channel was described to cause a phenotype similar to NCL.</p></sec><sec><title>Results</title><p>Two full-length cDNA splice variants of the canine <italic>CLCN3 </italic>gene are reported. The current canine whole genome sequence assembly was used for gene structure analyses and revealed 13 coding <italic>CLCN3 </italic>exons in 52 kb of genomic sequence. Sequence analysis of the coding exons and flanking intron regions of <italic>CLCN3 </italic>using six NCL-affected Tibetan terrier dogs and an NCL-affected Polish Owczarek Nizinny (PON) dog, as well as eight healthy Tibetan terrier dogs revealed 13 SNPs. No consistent <italic>CLCN3 </italic>haplotype was associated with NCL.</p></sec><sec><title>Conclusion</title><p>For the examined animals we excluded the complete coding region and adjacent intronic regions of canine <italic>CLCN3 </italic>to harbor disease-causing mutations. Therefore it seems to be unlikely that a mutation in this gene is responsible for the late-onset NCL phenotype in these two dog breeds.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Neuronal ceroid lipofuscinoses (NCL) represents a group of heritable neurodegenerative storage diseases in man, mice, and several domestic animals like cattle, sheep, goat, cat, and certain dog breeds [<xref ref-type="bibr" rid="B1">1</xref>]. NCL diseases are characterized by the accumulation of autofluorescent cytoplasmic storage bodies in cells of the brain and retina. NCL diseases cause neurological symptoms that progress relentlessly and culminate in a vegetative state in humans and premature death [<xref ref-type="bibr" rid="B2">2</xref>]. Canine late-onset NCL variants primarily affect Tibetan Terrier and Polish Owczarek Nizinny (PON) dogs. A monogenic autosomal recessive mode of transmission was suggested for those breeds [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>]. NCL-affected dogs represent valuable animal models to study human late-onset NCL variants since human families segregating for adult NCL are infrequent. Human NCL is a genetically heterogeneous disease with six identified disease genes (<italic>PPT1, TPP1, CLN3, CLN5, CLN6 </italic>and <italic>CLN8</italic>) [<xref ref-type="bibr" rid="B5">5</xref>]. Causal mutations within the canine orthologs of the six known human NCL genes have not been identified in NCL-affected Tibetan Terrier and PON dogs [<xref ref-type="bibr" rid="B6">6</xref>-<xref ref-type="bibr" rid="B9">9</xref>]. Single point mutations in the coding regions of the canine <italic>CLN8 </italic>and <italic>CLN5 </italic>genes were found in affected English Setter and Border collie dogs, respectively, showing juvenile NCL [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B10">10</xref>]. There are still undiscovered loci causing NCL beside the six known human genes, as indicated by findings in NCL-affected domestic and laboratory animals. In White Swedish Landrace sheep a <italic>CTSD </italic>mutation was reported and a mutation within the ortholog canine <italic>CTSD </italic>gene was detected in NCL-affected American Bulldogs [<xref ref-type="bibr" rid="B11">11</xref>]. Recently, <italic>CTSD </italic>was excluded as candidate gene in NCL-affected Tibetan Terrier and PON dogs [<xref ref-type="bibr" rid="B12">12</xref>]. In mice the chloride channel 3 gene (<italic>Clcn3</italic>) encoding an intracellular chloride channel was described to cause a phenotype similar to NCL [<xref ref-type="bibr" rid="B13">13</xref>]. <italic>Clcn3</italic>-deficient mice are characterized by developmental retardation and higher mortality combined with neurological manifestations such as blindness, motor coordination deficit, and spontaneous hyperlocomotion similar to human and canine NCL. To evaluate whether the <italic>CLCN3 </italic>gene is involved in the NCL-affected Tibetan Terrier and PON dogs, we determined the full-length cDNA sequence, characterized the gene structure, and analyzed the coding sequence of the canine ortholog.</p></sec><sec><title>Results and discussion</title><sec><title>Sequence analysis</title><p>RT-PCR from canine lung mRNA amplified two splice variants, which were verified by direct DNA-sequencing of the RT-PCR products. Similar to the human <italic>CLCN3 </italic>sequence the alternative usage of exon 12 produces the shorter <italic>CLCN3 </italic>and the longer <italic>CLCN3 </italic>isoform e, respectively (Figure <xref ref-type="fig" rid="F1">1</xref>). Overlapping canine cDNA fragments containing all junctions between the exons were generated by RT-PCR, sequenced, and used for comparison with the genomic sequence. These analyses indicated that the canine <italic>CLCN3 </italic>gene consists of 13 exons separated by twelve introns. The canine <italic>CLCN3 </italic>gene spans 52 kb (Figure <xref ref-type="fig" rid="F1">1</xref>) compared to 14 exons over 100 kb in human <italic>CLCN3 </italic>(NCBI build 35.1)) because in dog no untranslated 5'-exon is used. All splice donor/splice acceptor sites conform to the GT/AG rule. The experimentally verified existence of the two alternative splice variants is in agreement with the initially identified canine 5'-EST sequences (Figure <xref ref-type="fig" rid="F1">1</xref>). In dog the shorter <italic>CLCN3 </italic>transcript [EMBL:AM048629] contains an open reading frame of 2,376 bp encoding a protein of 791 amino acids. The longer canine <italic>CLCN3 </italic>isoform e transcript [EMBL:AM048628] contains an open reading frame of 2,517 bp encoding a sequence of 838 amino acids.</p><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>Genomic structure of the canine <italic>CLCN3 </italic>gene</bold>. Translated exons are shown as solid boxes, untranslated regions of exons as shaded boxes. The two alternative gene transcripts are shown below.</p></caption><graphic xlink:href="1471-2156-7-13-1"/></fig></sec><sec><title>Mutation analysis</title><p>A total of 13 sequence polymorphisms (Table <xref ref-type="table" rid="T1">1</xref>) were found in the examined dogs as compared to the <italic>CLCN3 </italic>reference sequence of the current dog genome assembly (boxer genome assembly 1.1). The codon in exon 2 with the A/G transition codes for glycine in both SNP variants and the codon in exon 9 with the A/G transition codes for proline in both SNP variants. None of the 11 intronic polymorphisms did affect splice sites in the <italic>CLCN3 </italic>gene. For the single PON dog there were seven polymorphisms compared to the Boxer reference sequence (Table <xref ref-type="table" rid="T1">1</xref>).</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Polymorphisms and observed haplotypes in the canine <italic>CLCN3 </italic>gene</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">Position<sup>1</sup></td><td align="center">Boxer<sup>2</sup></td><td align="center">Haplotype</td><td align="center" colspan="6">Tibetan Terrier</td><td align="center" colspan="2">PON</td></tr><tr><td></td><td></td><td></td><td align="center">1</td><td align="center">2</td><td align="center">3</td><td align="center">4</td><td align="center">5</td><td align="center">6</td><td align="center">1</td><td align="center">2</td></tr></thead><tbody><tr><td align="left">intron 1</td><td align="center">16409</td><td align="center">T</td><td align="center">T</td><td align="center">T</td><td align="center">T</td><td align="center">T</td><td align="center">T</td><td align="center">T</td><td align="center">T</td><td align="center">C</td></tr><tr><td align="left">exon 2</td><td align="center">2</td><td align="center">A</td><td align="center">A</td><td align="center">A</td><td align="center">A</td><td align="center">A</td><td align="center">A</td><td align="center">G</td><td align="center">A</td><td align="center">A</td></tr><tr><td align="left">intron 2</td><td align="center">3</td><td align="center">G</td><td align="center">A</td><td align="center">G</td><td align="center">G</td><td align="center">A</td><td align="center">G</td><td align="center">A</td><td align="center">G</td><td align="center">G</td></tr><tr><td align="left">intron 5</td><td align="center">10</td><td align="center">G</td><td align="center">A</td><td align="center">A</td><td align="center">A</td><td align="center">A</td><td align="center">A</td><td align="center">A</td><td align="center">A</td><td align="center">A</td></tr><tr><td align="left">intron 6</td><td align="center">40</td><td align="center">A</td><td align="center">A</td><td align="center">A</td><td align="center">A</td><td align="center">A</td><td align="center">A</td><td align="center">A</td><td align="center">del</td><td align="center">del</td></tr><tr><td align="left">intron 6</td><td align="center">2861</td><td align="center">T</td><td align="center">T</td><td align="center">T</td><td align="center">C</td><td align="center">C</td><td align="center">T</td><td align="center">T</td><td align="center">T</td><td align="center">T</td></tr><tr><td align="left">intron 6</td><td align="center">3061</td><td align="center">C</td><td align="center">G</td><td align="center">G</td><td align="center">G</td><td align="center">G</td><td align="center">G</td><td align="center">C</td><td align="center">G</td><td align="center">G</td></tr><tr><td align="left">intron 6</td><td align="center">3266</td><td align="center">G</td><td align="center">A</td><td align="center">A</td><td align="center">A</td><td align="center">A</td><td align="center">A</td><td align="center">G</td><td align="center">A</td><td align="center">A</td></tr><tr><td align="left">intron 6</td><td align="center">3270</td><td align="center">G</td><td align="center">A</td><td align="center">G</td><td align="center">G</td><td align="center">A</td><td align="center">A</td><td align="center">A</td><td align="center">G</td><td align="center">G</td></tr><tr><td align="left">intron 6</td><td align="center">3291</td><td align="center">C</td><td align="center">T</td><td align="center">T</td><td align="center">T</td><td align="center">T</td><td align="center">T</td><td align="center">C</td><td align="center">T</td><td align="center">T</td></tr><tr><td align="left">intron 7</td><td align="center">38</td><td align="center">G</td><td align="center">G</td><td align="center">A</td><td align="center">G</td><td align="center">G</td><td align="center">G</td><td align="center">G</td><td align="center">G</td><td align="center">G</td></tr><tr><td align="left">intron 7</td><td align="center">144</td><td align="center">C</td><td align="center">T</td><td align="center">C</td><td align="center">T</td><td align="center">T</td><td align="center">T</td><td align="center">T</td><td align="center">C</td><td align="center">C</td></tr><tr><td align="left">exon 9</td><td align="center">6</td><td align="center">A</td><td align="center">G</td><td align="center">G</td><td align="center">G</td><td align="center">G</td><td align="center">G</td><td align="center">G</td><td align="center">G</td><td align="center">G</td></tr></tbody></table><table-wrap-foot><p><sup>1 </sup>Numbering refers to the position of the polymorphic nucleotide within the given exon or intron respectively.</p><p><sup>2 </sup>Nucleotide refers to the publicly available dog genome sequence (AAEX01020012) from the boxer named Tasha.</p></table-wrap-foot></table-wrap><p>Assuming linkage disequilibrium between the polymorphic loci six different haplotypes could be constructed for the SNP genotypes in the Tibetan Terrier dogs (Table <xref ref-type="table" rid="T1">1</xref>). Four out of six haplotypes occurred in both, affected and unaffected dogs, respectively (Table <xref ref-type="table" rid="T2">2</xref>). Only the haplotypes 3 and 4 occurred in a single heterozygous NCL-affected Tibetan Terrier dog (Table <xref ref-type="table" rid="T2">2</xref>). Due to the assumption of a single recessive founder mutation within this breed we expect homozygosity in affected individuals. Table <xref ref-type="table" rid="T2">2</xref> summarizes the haplotype distribution among the NCL-affected and the clinical unsuspicious dogs. The chi-square statistic for testing these haplotypes for association with disease status in the Tibetan Terrier dogs was calculated as 5.5786 with degree of freedom 1, which had a p-value of 0.80, indicating no significant association.</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p><italic>CLCN3 </italic>genotypes in NCL-affected and control dogs</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">Genotype</td><td align="center" colspan="5">Tibetan Terrier</td><td align="center">PON</td></tr><tr><td></td><td align="center">1/1</td><td align="center">1/2</td><td align="center">3/4</td><td align="center">1/5</td><td align="center">1/6</td><td align="center">1/2</td></tr></thead><tbody><tr><td align="left">NCL-affected (n)</td><td align="center">4</td><td></td><td align="center">1</td><td align="center">1</td><td></td><td align="center">1</td></tr><tr><td align="left">NCL-non-affected (n)</td><td align="center">5</td><td align="center">1</td><td></td><td align="center">1</td><td align="center">1</td><td></td></tr></tbody></table><table-wrap-foot><p><sup>1 </sup>Genotypes correspond to the deduced haplotypes shown in Table 1.</p></table-wrap-foot></table-wrap></sec></sec><sec><title>Conclusion</title><p>The presented data indicate that the detected polymorphisms in the coding and adjacent intronic regions of canine <italic>CLCN3 </italic>can be excluded as disease harboring mutations in the examined dogs. Therefore it seems to be likely that the entire <italic>CLCN3 </italic>can be excluded as a candidate gene for the late-onset NCL phenotype in Tibetan Terrier and PON dogs. As the candidate gene approach did not reveal the causative gene in Tibetan Terrier and PON dogs it might be indicated to perform a genome wide linkage scan using NCL segregating families to map the canine chromosome region harboring the deleterious gene.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Sequence analysis</title><p>The human reference <italic>CLCN3 </italic>mRNA [GenBank:<ext-link ext-link-type="gen" xlink:href="NM_001829">NM_001829</ext-link>] was used as query in cross-species BLAST searches against the dog genome assembly (Boxer genome assembly 1.1). A single canine genomic contig of 577,638 bp was isolated [GenBank:<ext-link ext-link-type="gen" xlink:href="AAEX01020012">AAEX01020012</ext-link>]. The human mRNA sequence was used to identify putative exons in the canine genomic sequence used for dog specific RACE primer design. Total RNA from lung tissue of a normal female Beagle (Biocat, Heidelberg, Germany) was used for amplification of RACE PCR products. Isolation of full length cDNA for the canine <italic>CLCN3 </italic>gene was achieved by a modified rapid amplification of cDNA ends (RACE) protocol with the FirstChoiceTM RNA ligase-mediated (RLM)-RACE kit (Ambion Europe, Huntingdon, UK). Briefly, in RLM-RACE uncapped RNAs were dephosphorylated before the cap of full-length messenger RNAs (mRNAs) was removed enzymatically. After this step an RNA oligonucleotide adaptor was ligated to the 5'-end of the decapped mRNAs. As only full-length RNAs carried a 5'-phosphate group, the adaptor was expected to ligate exclusively to full-length mRNAs, while the dephosphorylated other RNAs were not able to undergo a ligation reaction. RT-PCR using two pairs of nested gene-specific (Table <xref ref-type="table" rid="T3">3</xref>) and adaptor-specific primer pairs (Ambion) were then used to amplify the complete 5'-end of the <italic>CLCN3 </italic>cDNA according to the instructions of the manufacturer. Similarly, the 3'-end was amplified using two pairs of nested gene-specific and 3'-adaptor-specific primers. 5'- and 3'-RACE products and an additional 1885 bp RT-PCR product using sense and antisense primers from exon 1 and 10 (Table <xref ref-type="table" rid="T3">3</xref>) were cloned into pDrive plasmid vectors using the Qiagen PCR cloning kit (Qiagen, Hilden, Germany) and several clones were sequenced. The obtained canine cDNA sequences were aligned with partially overlapping canine EST sequences corresponding to the human <italic>CLCN3 </italic>[GenBank:<ext-link ext-link-type="gen" xlink:href="BM537636">BM537636</ext-link>,<ext-link ext-link-type="gen" xlink:href="CF411209">CF411209</ext-link>,<ext-link ext-link-type="gen" xlink:href="BI398115">BI398115</ext-link>,<ext-link ext-link-type="gen" xlink:href="BU749098">BU749098</ext-link>,<ext-link ext-link-type="gen" xlink:href="BQ839554">BQ839554</ext-link>], and <italic>CLCN3 </italic>isoform e [GenBank:<ext-link ext-link-type="gen" xlink:href="BM536915">BM536915</ext-link>], respectively. The exact canine genomic structure was determined using the mRNA-to-genomic alignment program Spidey [<xref ref-type="bibr" rid="B14">14</xref>].</p><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Primer sequences for the amplification of canine <italic>CLCN3 </italic>cDNA</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">Primer</td><td align="center">Sequence (5' &#x02013; 3')</td><td align="center">Localization within canine <italic>CLCN3</italic></td><td align="center">T<sub>M</sub>(&#x000b0;C)</td></tr></thead><tbody><tr><td align="left">5' RACE outer primer</td><td align="center">TGTACGAGCCAGGACCTTCT</td><td align="center">exon 4/exon 5 junction</td><td align="center">60</td></tr><tr><td align="left">5' RACE inner primer</td><td align="center">TTTGTCATTTCCCATGCTGA</td><td align="center">exon 2</td><td align="center">60</td></tr><tr><td align="left">3' RACE outer primer</td><td align="center">TGCTTTAGTGGCTGCATTTG</td><td align="center">exon 8</td><td align="center">60</td></tr><tr><td align="left">3' RACE inner primer</td><td align="center">TGACTGTCTCCCTGGTGGTT</td><td align="center">exon 10</td><td align="center">60</td></tr><tr><td align="left">CLCN3_F1</td><td align="center">ATGGATGCTGCTTCTGATCC</td><td align="center">exon 1</td><td align="center">60</td></tr><tr><td align="left">CLCN3_R10</td><td align="center">CAGCAGCCAGAGTGGTATGA</td><td align="center">exon 10</td><td align="center">60</td></tr></tbody></table></table-wrap></sec><sec><title>Mutation analysis</title><p>Genomic DNA was isolated from a single NCL-affected PON dog, six unrelated NCL-affected Tibetan Terrier dogs, and eight unrelated clinical unsuspicious Tibetan Terrier dogs (&#x0003e; 8 years old). Clinical neurologic, behavioral, and ophthalmologic evaluations were performed on each dog by a single external consultant veterinarian [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B15">15</xref>]. The phenotypes of the affected animals have been confirmed by detection of autofluorescent cytoplasmic inclusions within neurons throughout the retina and brain after necropsy. The 13 <italic>CLCN3 </italic>exons with flanking sequences were PCR amplified and directly sequenced with the DYEnamic ET Terminator kit (Amersham Biosciences, Freiburg, Germany) and a MegaBACE 1000 capillary sequencer (Amersham Biosciences), using PCR primers listed in table <xref ref-type="table" rid="T4">4</xref> as sequencing primers. The association analysis for this paper was generated using SAS/HAPLOTYPE software, Version 2.1.39 of the SAS System for Windows (2003 SAS Institute Inc., Cary, NC, USA).</p><table-wrap position="float" id="T4"><label>Table 4</label><caption><p>Primer sequences for the amplification of canine <italic>CLCN3 </italic>exons</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">Forward primer</td><td align="center">Sequence (5' &#x02013; 3')</td><td align="center">Reverse primer</td><td align="center">Sequence (5' &#x02013; 3')</td><td align="center">T<sub>M</sub>(&#x000b0;C)</td><td align="center">Product size (bp)</td></tr></thead><tbody><tr><td align="left">CLCN3_Ex1_F</td><td align="center">AGCAGGGGTGGAAGAAATG</td><td align="center">CLCN3_Ex1_R</td><td align="center">AACTACAGAACCGCCCAGC</td><td align="center">60</td><td align="center">233</td></tr><tr><td align="left">CLCN3_Ex2_F</td><td align="center">ACCTAGTTCACCATTGTCTCTCA</td><td align="center">CLCN3_Ex2_R</td><td align="center">TATTTTGGCTGCCAGAGGTC</td><td align="center">60</td><td align="center">312</td></tr><tr><td align="left">CLCN3_Ex3_F</td><td align="center">ACCCCTTGCTCTCAAATCCT</td><td align="center">CLCN3_Ex3_R</td><td align="center">TTGTAGGGTGAAGGAGAGAACT</td><td align="center">60</td><td align="center">418</td></tr><tr><td align="left">CLCN3_Ex4_F</td><td align="center">GTCTCAACACTCCAAAAGTGGAC</td><td align="center">CLCN3_Ex4_R</td><td align="center">CTGTAATTAAACGGAGACTCATCTCA</td><td align="center">60</td><td align="center">321</td></tr><tr><td align="left">CLCN3_Ex5_F</td><td align="center">TGTGGAAGTAAGCCAAGAAACTC</td><td align="center">CLCN3_Ex5_R</td><td align="center">CTCCCCCTAAAGGCAAAAAG</td><td align="center">60</td><td align="center">318</td></tr><tr><td align="left">CLCN3_Ex6_F</td><td align="center">AAGTGTTCCTGTTTCCTGAATGA</td><td align="center">CLCN3_Ex6_R</td><td align="center">GACTGAGCAGTACTGGGGATG</td><td align="center">60</td><td align="center">459</td></tr><tr><td align="left">CLCN3_Ex7_F</td><td align="center">TTGGAAAGAGGTAGCCATCG</td><td align="center">CLCN3_Ex7_R</td><td align="center">GGCTTTTCTCAAGGTAAAGAACAT</td><td align="center">60</td><td align="center">936</td></tr><tr><td align="left">CLCN3_Ex8_F</td><td align="center">GCTGCAGCAAAAATTAGACCA</td><td align="center">CLCN3_Ex8_R</td><td align="center">AAATGGAACCCAAAAGATAAGAA</td><td align="center">60</td><td align="center">781</td></tr><tr><td align="left">CLCN3_Ex9_F</td><td align="center">AGTTTTATTTGTACTAGGATTTTGCTC</td><td align="center">CLCN3_Ex9_R</td><td align="center">CAATAGCAGTACTGTTTCATTTCTGTG</td><td align="center">60</td><td align="center">474</td></tr><tr><td align="left">CLCN3_Ex10_F</td><td align="center">TCCTGTCCTCCTTGACCAAT</td><td align="center">CLCN3_Ex10_R</td><td align="center">CCCCCAGAAACCCAACTAAT</td><td align="center">60</td><td align="center">579</td></tr><tr><td align="left">CLCN3_Ex11_F</td><td align="center">GGGACCAAATTCATGGGATA</td><td align="center">CLCN3_Ex11_R</td><td align="center">TGTTTTGGCAAAGATGTGGT</td><td align="center">60</td><td align="center">511</td></tr><tr><td align="left">CLCN3_Ex12_F</td><td align="center">GGACCTGGGATTTCGAACC</td><td align="center">CLCN3_Ex12_R</td><td align="center">TTATTCAGCAGGCATCTGGG</td><td align="center">60</td><td align="center">343</td></tr><tr><td align="left">CLCN3_Ex13_F</td><td align="center">ATCAAAGGATGGTTGCTGGA</td><td align="center">CLCN3_Ex13_R</td><td align="center">TTGCGATGTCGGAGTAACAG</td><td align="center">60</td><td align="center">647</td></tr></tbody></table></table-wrap></sec></sec><sec><title>Authors' contributions</title><p>AW did the mutation screen and drafted parts of the manuscript. OD proposed the idea and was responsible for funding. CD performed the RACE experiments, analyzed the sequence data, and performed manuscript editing.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>We thank Dr. med. vet. R. Brahm, Dortmund, Germany, for clinical examination and Dr. med. vet. K. Matiasek, Institute of Veterinary Pathology LMU Munich, Germany, for neuropathology.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jolly</surname><given-names>RD</given-names></name><name><surname>Walkley</surname><given-names>SU</given-names></name></person-group><article-title>Lysosomal storage diseases of animals: an essay in comparative pathology</article-title><source>Vet Pathol</source><year>1997</year><volume>34</volume><fpage>527</fpage><lpage>548</lpage><pub-id pub-id-type="pmid">9396134</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goebel</surname><given-names>HH</given-names></name><name><surname>Wisniewski</surname><given-names>KE</given-names></name></person-group><article-title>Current state of clinical and morphological features in human NCL</article-title><source>Brain Pathol</source><year>2004</year><volume>14</volume><fpage>61</fpage><lpage>69</lpage><pub-id pub-id-type="pmid">14997938</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Riis</surname><given-names>RC</given-names></name><name><surname>Cummings</surname><given-names>JF</given-names></name><name><surname>Loew</surname><given-names>ER</given-names></name><name><surname>de Lahunta</surname><given-names>A</given-names></name></person-group><article-title>Tibetan terrier model of canine ceroid lipofuscinosis</article-title><source>Am J Med Genet</source><year>1992</year><volume>42</volume><fpage>615</fpage><lpage>621</lpage><pub-id pub-id-type="pmid">1609844</pub-id><pub-id pub-id-type="doi">10.1002/ajmg.1320420437</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wrigstad</surname><given-names>A</given-names></name><name><surname>Nilsson</surname><given-names>SE</given-names></name><name><surname>Dubielzig</surname><given-names>R</given-names></name><name><surname>Narfstrom</surname><given-names>K</given-names></name></person-group><article-title>Neuronal ceroid lipofuscinosis in the Polish Owczarek Nizinny (PON) dog. A retinal study</article-title><source>Doc Ophthalmol</source><year>1995</year><volume>91</volume><fpage>33</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">8861635</pub-id><pub-id pub-id-type="doi">10.1007/BF01204622</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mole</surname><given-names>S</given-names></name></person-group><article-title>The genetic spectrum of human neuronal ceroid-lipofuscinoses</article-title><source>Brain Pathol</source><year>2004</year><volume>14</volume><fpage>70</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">14997939</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Katz</surname><given-names>ML</given-names></name><name><surname>Khan</surname><given-names>S</given-names></name><name><surname>Awano</surname><given-names>T</given-names></name><name><surname>Shahid</surname><given-names>SA</given-names></name><name><surname>Siakotos</surname><given-names>AN</given-names></name><name><surname>Johnson</surname><given-names>GS</given-names></name></person-group><article-title>A mutation in the <italic>CLN8 </italic>gene in English Setter dogs with neuronal ceroid-lipofuscinosis</article-title><source>Biochem Biophys Res Commun</source><year>2005</year><volume>327</volume><fpage>541</fpage><lpage>547</lpage><pub-id pub-id-type="pmid">15629147</pub-id><pub-id pub-id-type="doi">10.1016/j.bbrc.2004.12.038</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dr&#x000f6;gem&#x000fc;ller</surname><given-names>C</given-names></name><name><surname>W&#x000f6;hlke</surname><given-names>A</given-names></name><name><surname>Distl</surname><given-names>O</given-names></name></person-group><article-title>Evaluation of the canine <italic>TPP1 </italic>gene as a candidate for neuronal ceroid lipofuscinosis in Tibetan Terrier and Polish Owczarek Nizinny dogs</article-title><source>Anim Genet</source><year>2005</year><volume>36</volume><fpage>178</fpage><lpage>179</lpage><pub-id pub-id-type="pmid">15771740</pub-id><pub-id pub-id-type="doi">10.1111/j.1365-2052.2005.01254.x</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dr&#x000f6;gem&#x000fc;ller</surname><given-names>C</given-names></name><name><surname>W&#x000f6;hlke</surname><given-names>A</given-names></name><name><surname>Distl</surname><given-names>O</given-names></name></person-group><article-title>Characterization of candidate genes for neuronal ceroid lipofuscinosis in dog</article-title><source>J Hered</source><year>2005</year><volume>96</volume><fpage>735</fpage><lpage>738</lpage><pub-id pub-id-type="pmid">15958790</pub-id><pub-id pub-id-type="doi">10.1093/jhered/esi088</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shibuya</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>PC</given-names></name><name><surname>Katz</surname><given-names>ML</given-names></name><name><surname>Siakotos</surname><given-names>AN</given-names></name><name><surname>Nonneman</surname><given-names>DJ</given-names></name><name><surname>Johnson</surname><given-names>GS</given-names></name></person-group><article-title>Coding sequence and exon/intron organization of the canine <italic>CLN3 </italic>(Batten disease) gene and its exclusion as the locus for ceroid-lipofuscinosis in English setter dogs</article-title><source>J Neurosci Res</source><year>1998</year><volume>52</volume><fpage>268</fpage><lpage>275</lpage><pub-id pub-id-type="pmid">9590435</pub-id><pub-id pub-id-type="doi">10.1002/(SICI)1097-4547(19980501)52:3&#x0003c;268::AID-JNR3&#x0003e;3.0.CO;2-B</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Melville</surname><given-names>SA</given-names></name><name><surname>Wilson</surname><given-names>CL</given-names></name><name><surname>Chiang</surname><given-names>CS</given-names></name><name><surname>Studdert</surname><given-names>VP</given-names></name><name><surname>Lingaas</surname><given-names>F</given-names></name><name><surname>Wilton</surname><given-names>AN</given-names></name></person-group><article-title>A mutation in canine <italic>CLN5 </italic>causes neuronal ceroid lipofuscinosis in Border collie dogs</article-title><source>Genomics</source><year>2005</year><volume>86</volume><fpage>287</fpage><lpage>294</lpage><pub-id pub-id-type="pmid">16033706</pub-id><pub-id pub-id-type="doi">10.1016/j.ygeno.2005.06.005</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Awano</surname><given-names>T</given-names></name><name><surname>Katz</surname><given-names>ML</given-names></name><name><surname>O'Brien</surname><given-names>DP</given-names></name><name><surname>Taylor</surname><given-names>JF</given-names></name><name><surname>Evans</surname><given-names>J</given-names></name><name><surname>Khan</surname><given-names>S</given-names></name><name><surname>Sohar</surname><given-names>I</given-names></name><name><surname>Lobel</surname><given-names>P</given-names></name><name><surname>Johnson</surname><given-names>GS</given-names></name></person-group><article-title>A mutation in the cathepsin D gene (CTSD) in American Bulldogs with neuronal ceroid lipofuscinosis</article-title><source>Mol Genet Metab</source><comment>2005 Dec 28</comment><pub-id pub-id-type="pmid">16386934</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dr&#x000f6;gem&#x000fc;ller</surname><given-names>C</given-names></name><name><surname>W&#x000f6;hlke</surname><given-names>A</given-names></name><name><surname>Distl</surname><given-names>O</given-names></name></person-group><article-title>The canine <italic>CTSD </italic>gene as a candidate for late-onset neuronal ceroid lipofuscinosis</article-title><source>Anim Genet</source><year>2005</year><volume>36</volume><fpage>530</fpage><lpage>532</lpage><pub-id pub-id-type="pmid">16293139</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoshikawa</surname><given-names>M</given-names></name><name><surname>Uchida</surname><given-names>S</given-names></name><name><surname>Ezaki</surname><given-names>J</given-names></name><name><surname>Rai</surname><given-names>T</given-names></name><name><surname>Hayama</surname><given-names>A</given-names></name><name><surname>Kobayashi</surname><given-names>K</given-names></name><name><surname>Kida</surname><given-names>Y</given-names></name><name><surname>Noda</surname><given-names>M</given-names></name><name><surname>Koike</surname><given-names>M</given-names></name><name><surname>Uchiyama</surname><given-names>Y</given-names></name><name><surname>Marumo</surname><given-names>F</given-names></name><name><surname>Kominami</surname><given-names>E</given-names></name><name><surname>Sasaki</surname><given-names>S</given-names></name></person-group><article-title>CLC-3 deficiency leads to phenotypes similar to human neuronal ceroid lipofuscinosis</article-title><source>Genes Cells</source><year>2002</year><volume>7</volume><fpage>597</fpage><lpage>605</lpage><pub-id pub-id-type="pmid">12059962</pub-id><pub-id pub-id-type="doi">10.1046/j.1365-2443.2002.00539.x</pub-id></citation></ref><ref id="B14"><citation citation-type="other"><article-title>Spidey</article-title><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/IEB/Research/Ostell/Spidey/index.html"/></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Katz</surname><given-names>ML</given-names></name><name><surname>Narfstr&#x000f6;m</surname><given-names>K</given-names></name><name><surname>Johnson</surname><given-names>GS</given-names></name><name><surname>O'Brien</surname><given-names>DP</given-names></name></person-group><article-title>Assessment of retinal function and characterization of lysosomal storage body accumulation in the retinas and brains of Tibetan Terriers with ceroid-lipofuscinosis</article-title><source>Am J Vet Res</source><year>2005</year><volume>66</volume><fpage>67</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">15691038</pub-id><pub-id pub-id-type="doi">10.2460/ajvr.2005.66.67</pub-id></citation></ref></ref-list></back></article> 